FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Equine veterinary journal1997; 29(5); 349-359; doi: 10.1111/j.2042-3306.1997.tb03138.x

Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model.

Abstract: The objective of this study was to determine the effects of intra-articularly administered triamcinolone acetonide (TA) in exercised equine athletes with carpal osteochondral fragmentation. Eighteen horses were randomly assigned to each of 3 groups. An osteochondral chip fragment was created in one randomly chosen intercarpal joint of each horse. Both intercarpal joints in the placebo control group (CNT) horses were injected with intra-articular administration (IA) of polyionic fluid. Both joints in the TA control group (TA CNT) horses were treated with 12 mg of TA in the intercarpal joint without an osteochondral fragment, and the opposite intercarpal joint was injected with a similar volume of polyionic fluid. The TA treated group (TA TX) horses were treated with 12 mg of TA in the joint that contained the osteochondral fragment and the opposite intercarpal joint was injected with a similar volume of polyionic fluid. All horses were treated IA on days 13 and 27 after surgery and exercised on a high speed treadmill for 6 weeks starting on Day 14. Horses in the TA TX group were significantly less lame than horses in the CNT and TA CNT groups. Horses in either TA CNT or TA TX groups had lower total protein, and higher hyaluronan, and glycosaminoglycan concentrations in synovial fluid than did those in the CNT group. Synovial membrane collected from subjects in TA CNT and TA TX groups had significantly less inflammatory cell infiltration, subintimal hyperplasia and subintimal fibrosis compared to the CNT group. Articular cartilage histomorphological parameters were significantly better from the TA CNT and TA TX groups compared to the CNT group. In conclusions, results from this study support favourable effects of TA on degree of clinically detectable lameness, and on synovial fluid, synovial membrane, and articular cartilage morphological parameters, both with direct intra-articular administration and remote site administration as compared to placebo treatment. The clinical use of IA administered TA in horses may be therapeutically beneficial in selected cases of osteochondral fragmentation and osteoarthritis.
Get Full Text
Publication Date: 1997-11-05 PubMed ID: 9306060DOI: 10.1111/j.2042-3306.1997.tb03138.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Clinical Trial
  • Journal Article
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the impact of triamcinolone acetonide (TA), when administered intra-articularly, on horses with carpal osteochondral fragmentation who are also undergoing exercise. The study suggests that the use of TA could be therapeutically beneficial in certain instances of osteochondral fragmentation and osteoarthritis.

Research Methodology

  • The study included 18 horses that were split randomly into three groups.
  • In each horse, an osteochondral chip fragment was intentionally established in one of the intercarpal joints, chosen at random.
  • In the control group (CNT), both intercarpal joints were treated with an intra-articular injection of polyionic fluid.
  • For horses in the TA control group (TA CNT), one joint – which didn’t have the osteochondral fragment – was injected with 12 mg of TA, and the other was treated with a similar amount of the polyionic fluid.
  • The TA treated group (TA TX) comprised horses which had 12 mg of TA administered into the intercarpal joint containing the fragment, while the other joint received a similar volume of polyionic fluid.
  • All horses had treatments administered on days 13 and 27 after surgery and commenced a six-week high-speed treadmill exercise from day 14 onwards.

Research Findings

  • Horses in the TA TX group exhibited significantly less lameness compared to the CNT and TA CNT groups.
  • The total protein was lower, while hyaluronan and glycosaminoglycan concentrations in the synovial fluid were higher in horses from either the TA CNT or TA groups than those in the CNT group.
  • A lower rate of inflammatory cell infiltration, subintimal hyperplasia, and subintimal fibrosis were observed in the synovial membrane collected from those in TA CNT and TA TX groups compared to the CNT group.
  • Articular cartilage histomorphological parameters were significantly improved in the TA CNT and TA TX groups compared to the CNT group.

Conclusion

  • The findings from the study support the beneficial effects of TA in reducing clinically detectable lameness, and improving synovial fluid, synovial membrane, and articular cartilage morphological parameters, with both direct intra-articular administration and remote site administration.
  • These results suggest that intra-articularly administered TA could be a potential therapeutic aid for certain cases of osteochondral fragmentation and osteoarthritis in horses.

Cite This Article

APA
Frisbie DD, Kawcak CE, Trotter GW, Powers BE, Walton RM, McIlwraith CW. (1997). Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model. Equine Vet J, 29(5), 349-359. https://doi.org/10.1111/j.2042-3306.1997.tb03138.x

Publication

Equine veterinary journal
ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 29
Issue: 5
Pages: 349-359

Researcher Affiliations

Frisbie, D D
  • Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523, USA.
Kawcak, C E
    Trotter, G W
      Powers, B E
        Walton, R M
          McIlwraith, C W

            MeSH Terms

            • Animals
            • Anti-Inflammatory Agents / administration & dosage
            • Anti-Inflammatory Agents / pharmacology
            • Cartilage Diseases / drug therapy
            • Cartilage Diseases / etiology
            • Cartilage Diseases / veterinary
            • Cartilage, Articular / chemistry
            • Cartilage, Articular / drug effects
            • Cartilage, Articular / injuries
            • Glycosaminoglycans / analysis
            • Glycosaminoglycans / metabolism
            • Horse Diseases / drug therapy
            • Horse Diseases / etiology
            • Horse Diseases / metabolism
            • Horses / injuries
            • Horses / metabolism
            • Horses / physiology
            • Hyaluronic Acid / analysis
            • Hyaluronic Acid / metabolism
            • Hyperplasia / drug therapy
            • Hyperplasia / etiology
            • Hyperplasia / veterinary
            • Injections, Intra-Articular / methods
            • Injections, Intra-Articular / veterinary
            • Physical Conditioning, Animal / adverse effects
            • Physical Conditioning, Animal / physiology
            • Synovial Fluid / chemistry
            • Synovial Fluid / drug effects
            • Synovial Fluid / metabolism
            • Synovial Membrane / chemistry
            • Synovial Membrane / drug effects
            • Synovial Membrane / metabolism
            • Triamcinolone Acetonide / administration & dosage
            • Triamcinolone Acetonide / pharmacology

            Citations

            This article has been cited 37 times.
            1. Shahinfar S, Maibach H. Enigma of Intramuscular Triamcinolone Acetonide (Kenalog(®)) Efficacy. Clin Pharmacokinet 2023 Sep;62(9):1189-1199.
              doi: 10.1007/s40262-023-01297-5pubmed: 37598107google scholar: lookup
            2. Panizzi L, Dittmer KE, Vignes M, Doucet JS, Gedye K, Waterland MR, Rogers CW, Sano H, McIlwraith CW, Riley CB. Plasma and Synovial Fluid Cell-Free DNA Concentrations Following Induction of Osteoarthritis in Horses. Animals (Basel) 2023 Mar 14;13(6).
              doi: 10.3390/ani13061053pubmed: 36978592google scholar: lookup
            3. Clarke EJ, Johnson E, Caamaño Gutierrez E, Andersen C, Berg LC, Jenkins RE, Lindegaard C, Uvebrant K, Lundgren-Åkerlund E, Turlo A, James V, Jacobsen S, Peffers MJ. Temporal extracellular vesicle protein changes following intraarticular treatment with integrin α10β1-selected mesenchymal stem cells in equine osteoarthritis. Front Vet Sci 2022;9:1057667.
              doi: 10.3389/fvets.2022.1057667pubmed: 36504839google scholar: lookup
            4. Panizzi L, Vignes M, Dittmer KE, Waterland MR, Rogers CW, Sano H, McIlwraith CW, Pemberton S, Owen M, Riley CB. Infrared spectroscopy of serum fails to identify early biomarker changes in an equine model of traumatic osteoarthritis. Osteoarthr Cartil Open 2022 Dec;4(4):100297.
              doi: 10.1016/j.ocarto.2022.100297pubmed: 36474792google scholar: lookup
            5. Pezzanite LM, Chow L, Phillips J, Griffenhagen GM, Moore AR, Schaer TP, Engiles JB, Werpy N, Gilbertie J, Schnabel LV, Antczak D, Miller D, Dow S, Goodrich LR. TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant Staphylococcal septic arthritis in an equine model. Ann Transl Med 2022 Nov;10(21):1157.
              doi: 10.21037/atm-22-1746pubmed: 36467344google scholar: lookup
            6. Pezzanite LM, Chow L, Strumpf A, Johnson V, Dow SW. Immune Activated Cellular Therapy for Drug Resistant Infections: Rationale, Mechanisms, and Implications for Veterinary Medicine. Vet Sci 2022 Nov 4;9(11).
              doi: 10.3390/vetsci9110610pubmed: 36356087google scholar: lookup
            7. Anderson JR, Jacobsen S, Walters M, Bundgaard L, Diendorfer A, Hackl M, Clarke EJ, James V, Peffers MJ. Small non-coding RNA landscape of extracellular vesicles from a post-traumatic model of equine osteoarthritis. Front Vet Sci 2022;9:901269.
              doi: 10.3389/fvets.2022.901269pubmed: 36003409google scholar: lookup
            8. Kearney CM, Khatab S, van Buul GM, Plomp SGM, Korthagen NM, Labberté MC, Goodrich LR, Kisiday JD, Van Weeren PR, van Osch GJVM, Brama PAJ. Treatment Effects of Intra-Articular Allogenic Mesenchymal Stem Cell Secretome in an Equine Model of Joint Inflammation. Front Vet Sci 2022;9:907616.
              doi: 10.3389/fvets.2022.907616pubmed: 35812845google scholar: lookup
            9. Andersen C, Jacobsen S, Walters M, Lindegaard C. A detailed macroscopic scoring system for experimental post-traumatic Osteoarthritis in the equine middle carpal joint. BMC Res Notes 2022 Jun 27;15(1):226.
              doi: 10.1186/s13104-022-06116-xpubmed: 35761416google scholar: lookup
            10. Seabaugh KA, Barrett MF, Rao S, McIlwraith CW, Frisbie DD. Examining the Effects of the Oral Supplement Biota orientalis in the Osteochondral Fragment-Exercise Model of Osteoarthritis in the Horse. Front Vet Sci 2022;9:858391.
              doi: 10.3389/fvets.2022.858391pubmed: 35720848google scholar: lookup
            11. Wesdorp MA, Capar S, Bastiaansen-Jenniskens YM, Kops N, Creemers LB, Verhaar JAN, Van Osch GJVM, Wei W. Intra-articular Administration of Triamcinolone Acetonide in a Murine Cartilage Defect Model Reduces Inflammation but Inhibits Endogenous Cartilage Repair. Am J Sports Med 2022 May;50(6):1668-1678.
              doi: 10.1177/03635465221083693pubmed: 35315287google scholar: lookup
            12. Menarim BC, El-Sheikh Ali H, Loux SC, Scoggin KE, Kalbfleisch TS, MacLeod JN, Dahlgren LA. Transcriptional and Histochemical Signatures of Bone Marrow Mononuclear Cell-Mediated Resolution of Synovitis. Front Immunol 2021;12:734322.
              doi: 10.3389/fimmu.2021.734322pubmed: 34956173google scholar: lookup
            13. Pezzanite L, Chow L, Hendrickson D, Gustafson DL, Russell Moore A, Stoneback J, Griffenhagen GM, Piquini G, Phillips J, Lunghofer P, Dow S, Goodrich LR. Evaluation of Intra-Articular Amikacin Administration in an Equine Non-inflammatory Joint Model to Identify Effective Bactericidal Concentrations While Minimizing Cytotoxicity. Front Vet Sci 2021;8:676774.
              doi: 10.3389/fvets.2021.676774pubmed: 34095281google scholar: lookup
            14. Tellegen A, Beukers M, Rudnik-Jansen I, van Klaveren N, How KL, Woike N, Mihov G, Thies J, Teske E, Creemers L, Tryfonidou M, Meij B. Intra-Articular Slow-Release Triamcinolone Acetonide from Polyesteramide Microspheres as a Treatment for Osteoarthritis. Pharmaceutics 2021 Mar 11;13(3).
              doi: 10.3390/pharmaceutics13030372pubmed: 33799665google scholar: lookup
            15. Alves JC, Santos A, Jorge P, Lavrador C, Carreira LM. The intra-articular administration of triamcinolone hexacetonide in the treatment of osteoarthritis. Its effects in a naturally occurring canine osteoarthritis model. PLoS One 2021;16(1):e0245553.
              doi: 10.1371/journal.pone.0245553pubmed: 33471857google scholar: lookup
            16. Sullivan SN, Altmann NN, Brokken MT, Durgam SS. In vitro Effects of Methylprednisolone Acetate on Equine Deep Digital Flexor Tendon-Derived Cells. Front Vet Sci 2020;7:486.
              doi: 10.3389/fvets.2020.00486pubmed: 32851046google scholar: lookup
            17. Chakrabarti S, Ai M, Henson FMD, Smith ESJ. Peripheral mechanisms of arthritic pain: A proposal to leverage large animals for in vitro studies. Neurobiol Pain 2020 Aug-Dec;8:100051.
              doi: 10.1016/j.ynpai.2020.100051pubmed: 32817908google scholar: lookup
            18. Donnell JR, Frisbie DD. Use of firocoxib for the treatment of equine osteoarthritis. Vet Med (Auckl) 2014;5:159-168.
              doi: 10.2147/VMRR.S70207pubmed: 32670856google scholar: lookup
            19. El-Rahman GIA, Behairy A, Elseddawy NM, Batiha GE, Hozzein WN, Khodeer DM, Abd-Elhakim YM. Saussurea lappa Ethanolic Extract Attenuates Triamcinolone Acetonide-Induced Pulmonary and Splenic Tissue Damage in Rats via Modulation of Oxidative Stress, Inflammation, and Apoptosis. Antioxidants (Basel) 2020 May 8;9(5).
              doi: 10.3390/antiox9050396pubmed: 32397156google scholar: lookup
            20. Bodick N, Williamson T, Strand V, Senter B, Kelley S, Boyce R, Lightfoot-Dunn R. Local Effects Following Single and Repeat Intra-Articular Injections of Triamcinolone Acetonide Extended-Release: Results from Three Nonclinical Toxicity Studies in Dogs. Rheumatol Ther 2018 Dec;5(2):475-498.
              doi: 10.1007/s40744-018-0125-3pubmed: 30203389google scholar: lookup
            21. Wernecke C, Braun HJ, Dragoo JL. The Effect of Intra-articular Corticosteroids on Articular Cartilage: A Systematic Review. Orthop J Sports Med 2015 May;3(5):2325967115581163.
              doi: 10.1177/2325967115581163pubmed: 26674652google scholar: lookup
            22. Goodrich LR, Grieger JC, Phillips JN, Khan N, Gray SJ, McIlwraith CW, Samulski RJ. scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy. Gene Ther 2015 Jul;22(7):536-45.
              doi: 10.1038/gt.2015.21pubmed: 25902762google scholar: lookup
            23. Maninchedda U, Lepage OM, Gangl M, Hilairet S, Remandet B, Meot F, Penarier G, Segard E, Cortez P, Jorgensen C, Steinberg R. Development of an equine groove model to induce metacarpophalangeal osteoarthritis: a pilot study on 6 horses. PLoS One 2015;10(2):e0115089.
              doi: 10.1371/journal.pone.0115089pubmed: 25680102google scholar: lookup
            24. Franklin SP, Cook JL. Prospective trial of autologous conditioned plasma versus hyaluronan plus corticosteroid for elbow osteoarthritis in dogs. Can Vet J 2013 Sep;54(9):881-4.
              pubmed: 24155495
            25. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res 2012 Nov;1(11):297-309.
              doi: 10.1302/2046-3758.111.2000132pubmed: 23610661google scholar: lookup
            26. Gregory MH, Capito N, Kuroki K, Stoker AM, Cook JL, Sherman SL. A review of translational animal models for knee osteoarthritis. Arthritis 2012;2012:764621.
              doi: 10.1155/2012/764621pubmed: 23326663google scholar: lookup
            27. Lees P. Pharmacology of drugs used to treat osteoarthritis in veterinary practice. Inflammopharmacology 2003;11(4):385-99.
              doi: 10.1163/156856003322699564pubmed: 15035792google scholar: lookup
            28. Luedke LK, Seabaugh KA, Cooper BG, Snyder BD, Wimmer MA, McIlwraith CW, Barrett MF, Kawcak CE, Grinstaff MW, Goodrich LR. A Safety and Efficacy Study of a Synthetic Biolubricant in an Equine Model of Post-Traumatic Osteoarthritis. Animals (Basel) 2025 Feb 1;15(3).
              doi: 10.3390/ani15030404pubmed: 39943174google scholar: lookup
            29. Chow L, Kawahisa-Piquini G, Bass L, Hendrickson D, Patel A, Rockow M, Dow S, Pezzanite LM. Correlation of fecal microbiome dysregulation to synovial transcriptome in an equine model of obesity associated osteoarthritis. Ann Transl Med 2024 Dec 24;12(6):112.
              doi: 10.21037/atm-24-109pubmed: 39817240google scholar: lookup
            30. Guidoni K, Chiaradia E, Pepe M, Di Meo A, Tognoloni A, Seccaroni M, Beccati F. The Combined Use of Triamcinolone and Platelet-Rich Plasma in Equine Metacarpophalangeal Joint Osteoarthritis Treatments: An In Vivo and In Vitro Study. Animals (Basel) 2024 Dec 17;14(24).
              doi: 10.3390/ani14243645pubmed: 39765549google scholar: lookup
            31. Pirri C, Sorbino A, Manocchio N, Pirri N, Devito A, Foti C, Migliore A. Chondrotoxicity of Intra-Articular Injection Treatment: A Scoping Review. Int J Mol Sci 2024 Jun 26;25(13).
              doi: 10.3390/ijms25137010pubmed: 39000119google scholar: lookup
            32. Bensa A, Salerno M, Moraca G, Boffa A, McIlwraith CW, Filardo G. Intra-articular corticosteroids for the treatment of osteoarthritis: A systematic review and meta-analysis on the comparison of different molecules and doses. J Exp Orthop 2024 Jul;11(3):e12060.
              doi: 10.1002/jeo2.12060pubmed: 38911187google scholar: lookup
            33. Panizzi L, Vignes M, Dittmer KE, Waterland MR, Rogers CW, Sano H, McIlwraith CW, Riley CB. Infrared Spectroscopy of Synovial Fluid Shows Accuracy as an Early Biomarker in an Equine Model of Traumatic Osteoarthritis. Animals (Basel) 2024 Mar 22;14(7).
              doi: 10.3390/ani14070986pubmed: 38612225google scholar: lookup
            34. Andersen C, Walters M, Bundgaard L, Berg LC, Vonk LA, Lundgren-Åkerlund E, Henriksen BL, Lindegaard C, Skovgaard K, Jacobsen S. Intraarticular treatment with integrin α10β1-selected mesenchymal stem cells affects microRNA expression in experimental post-traumatic osteoarthritis in horses. Front Vet Sci 2024;11:1374681.
              doi: 10.3389/fvets.2024.1374681pubmed: 38596460google scholar: lookup
            35. Andersen C, Jacobsen S, Uvebrant K, Griffin JF 4th, Vonk LA, Walters M, Berg LC, Lundgren-Åkerlund E, Lindegaard C. Integrin α10β1-Selected Mesenchymal Stem Cells Reduce Pain and Cartilage Degradation and Increase Immunomodulation in an Equine Osteoarthritis Model. Cartilage 2025 Jun;16(2):250-264.
              doi: 10.1177/19476035231209402pubmed: 37990503google scholar: lookup
            36. Timkovich AE, Holling GA, Afzali MF, Kisiday J, Santangelo KS. TLR4 antagonism provides short-term but not long-term clinical benefit in a full-depth cartilage defect mouse model. Connect Tissue Res 2024 Jan;65(1):26-40.
              doi: 10.1080/03008207.2023.2269257pubmed: 37898909google scholar: lookup
            37. O'Brien TJ, Hollinshead F, Goodrich LR. Extracellular vesicles in the treatment and prevention of osteoarthritis: can horses help us translate this therapy to humans?. Extracell Vesicles Circ Nucl Acids 2023 Jun;4(2):151-169.
              doi: 10.20517/evcna.2023.11pubmed: 37829144google scholar: lookup
            Subscribe to our newsletter
            Join 99,727 horse owners like you who receive our email updates on horse health and nutrition.